PE20131065A1 - Composiciones farmaceuticas combinadas y metodo de tratamiento del vertigo, la cinetosis y la distonia vegetativa-vascular - Google Patents
Composiciones farmaceuticas combinadas y metodo de tratamiento del vertigo, la cinetosis y la distonia vegetativa-vascularInfo
- Publication number
- PE20131065A1 PE20131065A1 PE2013000111A PE2013000111A PE20131065A1 PE 20131065 A1 PE20131065 A1 PE 20131065A1 PE 2013000111 A PE2013000111 A PE 2013000111A PE 2013000111 A PE2013000111 A PE 2013000111A PE 20131065 A1 PE20131065 A1 PE 20131065A1
- Authority
- PE
- Peru
- Prior art keywords
- distonia
- kinetosis
- vegetative
- vascular
- treatment
- Prior art date
Links
- 208000012886 Vertigo Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 231100000889 vertigo Toxicity 0.000 title abstract 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 abstract 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 102000008052 Nitric Oxide Synthase Type III Human genes 0.000 abstract 1
- 108010075520 Nitric Oxide Synthase Type III Proteins 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Alternative & Traditional Medicine (AREA)
- Cardiology (AREA)
- Mycology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
Abstract
REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: a) UNA FORMA ACTIADA-POTENCIADA DE ANTICUERPOS CONTRA LA PROTEINA S-100 ESPECIFICA DEL CEREBRO TAL COMO LA PROTEINA S-100 BOVINA QUE TIENE LAS SECUENCIAS SEQ ID NO:9, SEQ ID NO:11, SEQ ID NO:11 O SEQ ID NO:12 Y b) UNA FORMA ACTIVADA-POTENCIADA DE ANTICUERPOS CONTRA LA OXIDO NITRICO SINTASA (NOS) ENDOTELIAL TAL COMO NOS HUMANA. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE LA DISTONIA VEGETATIVA VASCULAR, LA CINETOSIS Y VERTIGO POR DIVERSAS CAUSAS
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010130353/15A RU2542445C2 (ru) | 2010-07-21 | 2010-07-21 | Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера |
| RU2010130356/15A RU2542453C2 (ru) | 2010-07-21 | 2010-07-21 | Лекарственное средство и способ лечения вегето-сосудистой дистонии, синдрома головокружения различного генеза и кинетозов |
| RU2011127052/15A RU2503462C2 (ru) | 2011-07-01 | 2011-07-01 | Способ лечения головокружения различного генеза, кинетозов и вегето-сосудистой дистонии (варианты) и лекарственное средство |
| RU2011127058/15A RU2536232C2 (ru) | 2011-07-01 | 2011-07-01 | Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20131065A1 true PE20131065A1 (es) | 2013-09-23 |
Family
ID=44899157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2013000111A PE20131065A1 (es) | 2010-07-21 | 2011-07-15 | Composiciones farmaceuticas combinadas y metodo de tratamiento del vertigo, la cinetosis y la distonia vegetativa-vascular |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20130058981A1 (es) |
| EP (1) | EP2596018A2 (es) |
| JP (2) | JP2013536174A (es) |
| KR (1) | KR20130102542A (es) |
| CN (1) | CN103124741A (es) |
| AR (1) | AR082314A1 (es) |
| AU (1) | AU2011281248B2 (es) |
| BR (1) | BR112013001296A2 (es) |
| CA (1) | CA2805985A1 (es) |
| CL (1) | CL2013000201A1 (es) |
| DE (1) | DE112011102397T5 (es) |
| EA (1) | EA029998B1 (es) |
| ES (1) | ES2446643R1 (es) |
| FR (1) | FR2962910A1 (es) |
| GB (1) | GB2496342B (es) |
| IL (1) | IL224336A (es) |
| IT (1) | ITTO20110630A1 (es) |
| MX (1) | MX355371B (es) |
| NZ (1) | NZ606988A (es) |
| PE (1) | PE20131065A1 (es) |
| PH (1) | PH12013500141A1 (es) |
| SG (2) | SG10201505676RA (es) |
| WO (1) | WO2012010974A2 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| WO2012007845A2 (en) * | 2010-07-15 | 2012-01-19 | Oleg Iliich Epshtein | A method of increasing the effect of an activated-potentiated form of an antibody |
| CA2804967A1 (en) | 2010-07-15 | 2012-02-09 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
| PH12013500109A1 (en) | 2010-07-15 | 2015-07-03 | Oleg Iliich Epshtein | Pharmaceutical compositions and methods of treatment |
| KR20130103486A (ko) * | 2010-07-21 | 2013-09-23 | 올레그 일리치 엡쉬테인 | 당뇨병 및 대사성 장애의 치료를 위한 제약학적 복합 조성물 및 방법들 |
| CA2805963A1 (en) | 2010-07-21 | 2012-01-26 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| WO2012010978A2 (en) * | 2010-07-21 | 2012-01-26 | Oleg Iliich Epshtein | A method of treating alzheimer's disease |
| ITTO20110638A1 (it) | 2010-07-21 | 2012-01-22 | Oleg Iliich Epshtein | Composizione farmaceutica di combinazione e metodi per trattare patologie o stati patologici associati a patologie o stati patologici respiratori |
| SG10201403870XA (en) * | 2010-08-06 | 2014-08-28 | Oleg Iliich Epshtein | Combination Pharmaceutical Composition And Methods Of Treating And Preventing The Infectious Diseases |
| RU2013111961A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| RU2013111962A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
| RU2113230C1 (ru) | 1996-04-03 | 1998-06-20 | Ильчиков Михаил Захарович | Седативное лекарственное средство "авиаморе" |
| US6150500A (en) * | 1996-07-12 | 2000-11-21 | Salerno; John C. | Activators of endothelial nitric oxide synthase |
| US5849528A (en) * | 1997-08-21 | 1998-12-15 | Incyte Pharmaceuticals, Inc.. | Polynucleotides encoding a human S100 protein |
| RU2156621C1 (ru) * | 1999-03-04 | 2000-09-27 | Эпштейн Олег Ильич | Нейротропное лекарственное средство |
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| WO2002071928A2 (en) * | 2001-03-14 | 2002-09-19 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| RU2201255C1 (ru) * | 2001-12-26 | 2003-03-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции сосудистого тонуса |
| UA76639C2 (uk) * | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| UA76641C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
| US20070224201A1 (en) * | 2002-10-02 | 2007-09-27 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| AU2004222357C1 (en) | 2003-03-14 | 2009-11-19 | Nutrition Research, Inc. | Homeopathic formulations useful for treating pain and/or inflammation |
| WO2012007845A2 (en) * | 2010-07-15 | 2012-01-19 | Oleg Iliich Epshtein | A method of increasing the effect of an activated-potentiated form of an antibody |
| CA2804967A1 (en) * | 2010-07-15 | 2012-02-09 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
| PH12013500109A1 (en) * | 2010-07-15 | 2015-07-03 | Oleg Iliich Epshtein | Pharmaceutical compositions and methods of treatment |
| ITTO20110638A1 (it) * | 2010-07-21 | 2012-01-22 | Oleg Iliich Epshtein | Composizione farmaceutica di combinazione e metodi per trattare patologie o stati patologici associati a patologie o stati patologici respiratori |
| WO2012010978A2 (en) * | 2010-07-21 | 2012-01-26 | Oleg Iliich Epshtein | A method of treating alzheimer's disease |
| CA2805963A1 (en) * | 2010-07-21 | 2012-01-26 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| EP2596020A2 (en) * | 2010-07-21 | 2013-05-29 | Oleg Iliich Epshtein | Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy |
| KR20130103486A (ko) * | 2010-07-21 | 2013-09-23 | 올레그 일리치 엡쉬테인 | 당뇨병 및 대사성 장애의 치료를 위한 제약학적 복합 조성물 및 방법들 |
-
2011
- 2011-07-15 DE DE112011102397T patent/DE112011102397T5/de not_active Withdrawn
- 2011-07-15 JP JP2013520240A patent/JP2013536174A/ja active Pending
- 2011-07-15 SG SG10201505676RA patent/SG10201505676RA/en unknown
- 2011-07-15 CA CA2805985A patent/CA2805985A1/en not_active Abandoned
- 2011-07-15 MX MX2013000805A patent/MX355371B/es active IP Right Grant
- 2011-07-15 EP EP11773316.2A patent/EP2596018A2/en not_active Ceased
- 2011-07-15 SG SG2013004809A patent/SG187160A1/en unknown
- 2011-07-15 KR KR1020137004331A patent/KR20130102542A/ko not_active Ceased
- 2011-07-15 NZ NZ606988A patent/NZ606988A/en not_active IP Right Cessation
- 2011-07-15 WO PCT/IB2011/002378 patent/WO2012010974A2/en not_active Ceased
- 2011-07-15 US US13/135,887 patent/US20130058981A1/en not_active Abandoned
- 2011-07-15 AU AU2011281248A patent/AU2011281248B2/en not_active Ceased
- 2011-07-15 GB GB1302925.1A patent/GB2496342B/en not_active Expired - Fee Related
- 2011-07-15 PH PH1/2013/500141A patent/PH12013500141A1/en unknown
- 2011-07-15 FR FR1156477A patent/FR2962910A1/fr not_active Withdrawn
- 2011-07-15 BR BR112013001296A patent/BR112013001296A2/pt not_active IP Right Cessation
- 2011-07-15 PE PE2013000111A patent/PE20131065A1/es not_active Application Discontinuation
- 2011-07-15 CN CN2011800454598A patent/CN103124741A/zh active Pending
- 2011-07-15 IT IT000630A patent/ITTO20110630A1/it unknown
- 2011-07-15 ES ES201390010A patent/ES2446643R1/es active Pending
- 2011-07-15 EA EA201300127A patent/EA029998B1/ru not_active IP Right Cessation
- 2011-07-21 AR ARP110102644A patent/AR082314A1/es unknown
-
2013
- 2013-01-20 IL IL224336A patent/IL224336A/en active IP Right Grant
- 2013-01-21 CL CL2013000201A patent/CL2013000201A1/es unknown
-
2016
- 2016-07-01 JP JP2016131718A patent/JP2016199571A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AR082314A1 (es) | 2012-11-28 |
| SG10201505676RA (en) | 2015-08-28 |
| WO2012010974A2 (en) | 2012-01-26 |
| ES2446643A2 (es) | 2014-03-10 |
| EA029998B1 (ru) | 2018-06-29 |
| EA201300127A1 (ru) | 2013-12-30 |
| JP2016199571A (ja) | 2016-12-01 |
| CL2013000201A1 (es) | 2015-01-23 |
| GB2496342A (en) | 2013-05-08 |
| CA2805985A1 (en) | 2012-01-26 |
| MX2013000805A (es) | 2013-10-28 |
| MX355371B (es) | 2018-04-17 |
| EP2596018A2 (en) | 2013-05-29 |
| ITTO20110630A1 (it) | 2012-01-22 |
| US20130058981A1 (en) | 2013-03-07 |
| NZ606988A (en) | 2015-08-28 |
| PH12013500141A1 (en) | 2013-03-11 |
| CN103124741A (zh) | 2013-05-29 |
| GB201302925D0 (en) | 2013-04-03 |
| BR112013001296A2 (pt) | 2017-12-19 |
| FR2962910A1 (fr) | 2012-01-27 |
| AU2011281248B2 (en) | 2017-02-02 |
| KR20130102542A (ko) | 2013-09-17 |
| JP2013536174A (ja) | 2013-09-19 |
| AU2011281248A1 (en) | 2013-03-14 |
| GB2496342B (en) | 2017-12-06 |
| WO2012010974A8 (en) | 2013-04-25 |
| SG187160A1 (en) | 2013-02-28 |
| ES2446643R1 (es) | 2015-03-06 |
| WO2012010974A3 (en) | 2012-04-19 |
| DE112011102397T5 (de) | 2013-05-08 |
| IL224336A (en) | 2017-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20131065A1 (es) | Composiciones farmaceuticas combinadas y metodo de tratamiento del vertigo, la cinetosis y la distonia vegetativa-vascular | |
| BR112013027500A2 (pt) | liberação controlada de imunossupressores de nanotransportadores sintéticos | |
| AR090465A1 (es) | Formas solidas de un profarmaco de nucleotidos de tiofosforamidato | |
| WO2014145159A3 (en) | Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use | |
| PE20140978A1 (es) | Composicion farmaceutica solida que contiene amlodipina y losartan y el proceso para producirla | |
| MX2017006129A (es) | Métodos y formulaciones para tratar enfermedades vasculares de los ojos. | |
| PH12013501636A1 (en) | Treatment of osteoarthritis and pain | |
| UA116999C2 (uk) | Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить | |
| PE20151558A1 (es) | Inhibidores tripeptidicos de la epoxicetona proteasa | |
| PE20170908A1 (es) | VARIANTES DE INTERFERON a2b | |
| MX2017013949A (es) | Composiciones mectantes a base de seda y sus metodos. | |
| EA201300137A1 (ru) | Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний, связанных с нейродегенеративными зоболеваниями | |
| PE20220960A1 (es) | Proteinas de variantes de secuencias de aminoacidos de cry1da1 activas para lepidopteros | |
| MX390739B (es) | Composicion de hueso comprimido y metodo para usar la misma. | |
| SG10201811186XA (en) | Purification of proteins | |
| MX391136B (es) | FRAGMENTOS DE OspA ESTABILIZADOS CON CISTEÍNA Y MÉTODO DE USO | |
| BR112016023498A2 (pt) | composições para higiene bucal | |
| MX387756B (es) | Composiciones de matríces extracelulares. | |
| UA107836C2 (uk) | Метод лікування хвороби альцгеймера | |
| MX370990B (es) | Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos. | |
| PH12018550008A1 (en) | Selected amide of y-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse | |
| PE20160847A1 (es) | Nuevo compuesto para el tratamiento de hipoglicemia severa | |
| UA118653C2 (uk) | Суперагоністи глікопротеїнового гормону тривалої дії | |
| PE20160848A1 (es) | Nuevo compuesto para el tratamiento de hipoglicemia severa | |
| IN2014DN09812A (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |